摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-N-(1-(2-amino-3-phenylpropanoyl)piperidin-4-yl)-N-phenylpropionamide | 937738-85-7

中文名称
——
中文别名
——
英文名称
(S)-N-(1-(2-amino-3-phenylpropanoyl)piperidin-4-yl)-N-phenylpropionamide
英文别名
N-[1-[(2S)-2-amino-3-phenylpropanoyl]piperidin-4-yl]-N-phenylpropanamide
(S)-N-(1-(2-amino-3-phenylpropanoyl)piperidin-4-yl)-N-phenylpropionamide化学式
CAS
937738-85-7
化学式
C23H29N3O2
mdl
——
分子量
379.502
InChiKey
GQARBTXKMGQGGN-NRFANRHFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    28
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    66.6
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-N-(1-(2-amino-3-phenylpropanoyl)piperidin-4-yl)-N-phenylpropionamideN-甲基吗啉 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 1-羟基苯并三唑三氟乙酸 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 0.66h, 生成
    参考文献:
    名称:
    Chiral Effect of a Phe Residue in Position 3 of the Dmt1-l(or d)-Tic2 Analogues on Opioid Functional Activities
    摘要:
    In this letter, we describe a structure-activity relationships study, specifically related to the chirality of third amino acid residue in our H-Dmt-L(or D)-Tic analogues, of which C-terminus is attached to a piperidinyl moiety. Observed selectivities and functional activities of these analogues demonstrated that the chiralities of the second and third position residues are crucial for determining whether these ligands act as antagonists or agonists at the delta opioid receptor, but not at the mu opioid receptor.
    DOI:
    10.1021/ml400115n
  • 作为产物:
    描述:
    4-苯胺-1-苯甲基哌啶 在 palladium on activated charcoal N-甲基吗啉 、 TEA 、 氢气 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 1-羟基苯并三唑三氟乙酸 作用下, 以 乙醇 为溶剂, 反应 84.33h, 生成 (S)-N-(1-(2-amino-3-phenylpropanoyl)piperidin-4-yl)-N-phenylpropionamide
    参考文献:
    名称:
    Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at μ and δ opioid receptors
    摘要:
    New 4-anilidopiperidine analogues in which the phenethyl group of fentanyl was replaced by several aromatic ring-contained amino acids (or acids) were synthesized to study the biological effect of the substituents on mu and delta opioid receptor interactions. These analogues showed broad (47 nM-76 mu M) but selective (up to 17-fold) binding affinities at the V opioid receptor over the 6 opioid receptor, as predicted from the message-address concept. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.01.114
点击查看最新优质反应信息

文献信息

  • Development of Novel Enkephalin Analogues that Have Enhanced Opioid Activities at Both μ and δ Opioid Receptors
    作者:Yeon Sun Lee、Ravil Petrov、Chad K. Park、Shou-wu Ma、Peg Davis、Josephine Lai、Frank Porreca、Ruben Vardanyan、Victor J. Hruby
    DOI:10.1021/jm061465o
    日期:2007.11.1
    Enkephalin analogues with a 4-anilidopiperidine scaffold have been designed and synthesized to achieve therapeutic benefit for the treatment of pain due to mixed mu and delta opioid agonist activities. Ligand 16, in which a Dmt-substituted enkephalin-like structure was linked to the N-phenyl-N-piperidin-4-yl propionamide moiety, showed very high binding affinities (0.4 nM) at mu and delta receptors with an increased hydrophobicity (aLogP = 2.96). This novel lead compound was found to have very potent agonist activities in MVD (1.8 nM) and GPI (8.5 nM) assays.
  • Development of Potent μ and δ Opioid Agonists with High Lipophilicity
    作者:Yeon Sun Lee、Vinod Kulkarani、Scott M. Cowell、Shou-wu Ma、Peg Davis、Katherine E. Hanlon、Todd W. Vanderah、Josephine Lai、Frank Porreca、Ruben Vardanyan、Victor J. Hruby
    DOI:10.1021/jm100982d
    日期:2011.1.13
    An SAR study on the Dmt-substituted enkephalin-like tetrapeptide with a N-phenyl-N-piperidin-4-ylpropionamide moiety at the C-terminal was performed and has resulted in highly potent ligands at mu and delta opioid receptors In general, ligands with the substitution of D-Nle(2) and halogenation of the aromatic ring of Phe(4) showed highly increased opioid activities Ligand 6 with good biological activities in vitro demonstrated potent in vivo antihyperalgesic and antiallodynic effects in the tail-flick assay
  • Chiral Effect of a Phe Residue in Position 3 of the Dmt<sup>1</sup>-<scp>l</scp>(or <scp>d</scp>)-Tic<sup>2</sup> Analogues on Opioid Functional Activities
    作者:Yeon Sun Lee、HongChang Qu、Peg Davis、Shou-Wu Ma、Ruben Vardanyan、Josephine Lai、Frank Porreca、Victor J. Hruby
    DOI:10.1021/ml400115n
    日期:2013.7.11
    In this letter, we describe a structure-activity relationships study, specifically related to the chirality of third amino acid residue in our H-Dmt-L(or D)-Tic analogues, of which C-terminus is attached to a piperidinyl moiety. Observed selectivities and functional activities of these analogues demonstrated that the chiralities of the second and third position residues are crucial for determining whether these ligands act as antagonists or agonists at the delta opioid receptor, but not at the mu opioid receptor.
  • Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at μ and δ opioid receptors
    作者:Yeon Sun Lee、Joel Nyberg、Sharif Moye、Richard S. Agnes、Peg Davis、Shou-wu Ma、Josephine Lai、Frank Porreca、Ruben Vardanyan、Victor J. Hruby
    DOI:10.1016/j.bmcl.2007.01.114
    日期:2007.4
    New 4-anilidopiperidine analogues in which the phenethyl group of fentanyl was replaced by several aromatic ring-contained amino acids (or acids) were synthesized to study the biological effect of the substituents on mu and delta opioid receptor interactions. These analogues showed broad (47 nM-76 mu M) but selective (up to 17-fold) binding affinities at the V opioid receptor over the 6 opioid receptor, as predicted from the message-address concept. (c) 2007 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物